QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=F82851D227D6F47E10BF30F08CF5F35F;jsessionid=16B052629F019FEE38350BFB83DBA0E7;jsessionid=14E577CD213B8025E3CECB1361AF3374;jsessionid=C4A6936E25DA3A10971923138238DF44 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=F82851D227D6F47E10BF30F08CF5F35F;jsessionid=16B052629F019FEE38350BFB83DBA0E7;jsessionid=14E577CD213B8025E3CECB1361AF3374;jsessionid=C4A6936E25DA3A10971923138238DF44